rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
2
|
pubmed:dateCreated |
2008-4-2
|
pubmed:abstractText |
To evaluate the prevalence of human epidermal growth factor receptor 2 (HER2) gene overexpression in breast cancer patients encountered in Hong Kong and the concordance of HER2 findings from primary immunohistochemistry assays and confirmatory in-situ hybridisation assays.
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
1024-2708
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
14
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
130-5
|
pubmed:dateRevised |
2009-11-19
|
pubmed:meshHeading |
pubmed-meshheading:18382020-Adult,
pubmed-meshheading:18382020-Breast Neoplasms,
pubmed-meshheading:18382020-Carcinoma, Ductal,
pubmed-meshheading:18382020-Carcinoma, Lobular,
pubmed-meshheading:18382020-Cross-Sectional Studies,
pubmed-meshheading:18382020-Female,
pubmed-meshheading:18382020-Gene Amplification,
pubmed-meshheading:18382020-Gene Expression Regulation, Neoplastic,
pubmed-meshheading:18382020-Hong Kong,
pubmed-meshheading:18382020-Humans,
pubmed-meshheading:18382020-Immunohistochemistry,
pubmed-meshheading:18382020-In Situ Hybridization,
pubmed-meshheading:18382020-In Situ Hybridization, Fluorescence,
pubmed-meshheading:18382020-Middle Aged,
pubmed-meshheading:18382020-Neoplasm Staging,
pubmed-meshheading:18382020-Predictive Value of Tests,
pubmed-meshheading:18382020-Receptor, erbB-2,
pubmed-meshheading:18382020-Retrospective Studies
|
pubmed:year |
2008
|
pubmed:articleTitle |
HER2 overexpression of breast cancers in Hong Kong: prevalence and concordance between immunohistochemistry and in-situ hybridisation assays.
|
pubmed:affiliation |
Department of Clinical Oncology, Pamela Youde Nethersole Eastern Hospital, Chai Wan, Hong Kong. tkokyau@gmail.com
|
pubmed:publicationType |
Journal Article,
Comparative Study
|